Search results for Pamrevlumab
Pamrevlumab Biosimilar – Anti-CTGF, IGFBP-8 mAb – Research Grade, ProteoGenix, PX-TA1386
Description of Pamrevlumab Biosimilar - Anti-CTGF, IGFBP-8 mAb - Research Grade General information on Anti-CTGF/IGFBP-8[Homo sapiens] (Pamrevlumab) Monoclonal Antibody Pamrevlumab is investigated in the treatment of Type 2 Diabetes Mellitus and Kidney Disease.
Host
Reactivity
Applications
Conjugation
Pamrevlumab, Abbexa, abx831346
Pamrevlumab is a monoclonal antibody biosimilar expressed in CHO cells, targeting CTGF/IGFBP-8, for use in laboratory research applications. This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications.
Host
Human
Reactivity
Human
Applications
ELISA, WB
Conjugation
Unconjugated
Pamrevlumab Biosimilar - Research Grade, ichor.bio, ICH5754
Host
CHO Cells
Reactivity
Human
Applications
Conjugation
Please provide the required information below so that we can quickly source your products.